WP
LONA

Woodline Partners’s LeonaBio Inc LONA Stock Holding History

Woodline Partners’s Portfolio LONA Stock Details LONA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-19,759
Closed -$2.67M – 801
2022
Q1 		$2.67M Buy
+19,759
New +$2.08M 0.04% 339
2020
Q4 		– Sell
-7,252
Closed -$1.34M – 227
2020
Q3 		$1.34M Buy
+7,252
New +$1.21M 0.04% 168

Other funds holding LONA

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
PFO
Pathstone Family Office Englewood, New Jersey $13.1B AUM 20.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
BA
Bristlecone Advisors Bellevue, Washington $1.2B AUM 19.79% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Woodline Partners's LONA Position: Q2 2022 in Review

Woodline Partners sold out of LeonaBio Inc (LONA) in Q2 2022, closing a stake of 19,759 shares — an estimated $2.67M sold.

Woodline Partners first reported a position in LONA in Q3 2020 and held it in 2 quarters. The position peaked at $2.67M in Q1 2022. 98 funds tracked by Wall St. Rank hold LONA as of Q2 2022.

  • Woodline Partners reported no remaining LeonaBio Inc position as of Q2 2022 after selling out during the quarter.
  • Woodline Partners sold 19,759 LeonaBio Inc shares in Q2 2022, an estimated $2.67M.
  • Woodline Partners first reported a position in LeonaBio Inc in Q3 2020 and held it in 2 quarters.
  • Woodline Partners's LeonaBio Inc position peaked at $2.67M in Q1 2022.
  • 98 funds tracked by Wall St. Rank held LeonaBio Inc as of Q2 2022.

Based on Woodline Partners's 13F filing for Q2 2022, filed 15 Aug 2022.